RxDoctor Payments Data

Ariana Lopez Garcia

Urology · San Juan, PRNPI 1255861613

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,141 of the $3,555 with a category attached, or 60.2%. 15 manufacturers reported payments, led by Procept Biorobotics Corporation at 39.1% of the total. 2025 is the largest year on record at $2,323, more than ten times the $12 reported in 2020.

$3,555in general payments, 2019–2025

Across 39 payments — averaging $91.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Procept Biorobotics Corporation$1K
  • E.r. Squibb & Sons, L.L.C.$503
  • Teleflex LLC$466
  • Johnson & Johnson$418
  • Boston Scientific$152
  • Medtronic$129
  • plus $498 from 9 others

What the payments were for

  • Travel & lodging$1,41440%
  • Food & beverage$2,14160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Procept Biorobotics Corporation4$1,389
E.r. Squibb & Sons, L.L.C.5$503
Teleflex LLC5$466
Johnson & Johnson4$418
Boston Scientific3$152
Medtronic1$129
AbbVie1$125
Tolmar, Inc.5$105
Profound Medical Corp.1$69
Merck3$66
Pharmaand GmbH2$37
PBG Puerto Rico LLC2$30
Olympus Latin America, Inc.1$28
Genentech USA, Inc.1$21
Ferring Pharmaceuticals Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,555 in reported general payments places this provider in the 60th percentile of 122 urology providers in Puerto Rico.

See all urology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$16,909
Medicare patients
36
Services billed
121

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron106$49,015
Estradiol105$8,077
Tolterodine Tartrate ErTolterodine Tartrate34$2,478
Tamsulosin Hcl203$1,686
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip22$665
Finasteride45$438
Cephalexin35$346
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim71$308
Tolterodine Tartrate13$279
NitrofurantoinNitrofurantoin Macrocrystal14$225
Levofloxacin25$180
Oxybutynin Chloride ErOxybutynin Chloride15$143
Ciprofloxacin Hcl13$68

Paid to pharmacies, not to this prescriber.

Other urology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →